首页 | 本学科首页   官方微博 | 高级检索  
检索        

缺血性脑血管病老年患者临床诊治分析
引用本文:蒙泽明.缺血性脑血管病老年患者临床诊治分析[J].中国当代医药,2010,17(19):241-242.
作者姓名:蒙泽明
作者单位:广东省茂名农垦医院神经内科,广东,茂名,525000
摘    要:目的:探讨抗血小板聚集药阿昔单抗与溶栓疗法联合应用对缺血性脑血管疾病的临床疗效。方法:收集缺血性脑血管病患者50例,分为治疗组和对照组,治疗组给予阿昔单抗和溶栓疗法联合治疗,对照组给予单纯溶栓治疗。结果:治疗组与对照组的治疗效果有显著差异,阿昔单抗和溶栓疗法联合治疗的疗效明显高于单纯溶栓疗法组。结论:抗血小板聚集药阿昔单抗与溶栓疗法联合应用是治疗缺血性脑血管病的一种较好方案。

关 键 词:缺血性脑血管病  阿昔单抗  溶栓疗法

Anemic blood vessel of brain old age patient clinical diagnosis analysis
Authors:MENG Zeming
Institution:MENG Zeming(Department of Nerve Internal Medicine Maoming Agriculture and Reclamation Hospital,Guangdong Province,Maoming 525000,China)
Abstract:Objective:To investigate the effect of treatment for ischemic cerebrovascular disease using abciximab combined with thrombolytic therapy.Methods:50 patients of ischemic cerebrovascular disease were divided into treatment group and control group,the treatment group received abciximab combined with thrombolytic therapy,the control group received thrombolytic therapy.Results:The differences between treatment group and control group in treatment were significant.The abciximab combine with thrombolytic therapy was significantly higher than the simple thrombolytic therapy group. Conclusion:It is a good program to treat ischemic cerebrovascular disease using abciximab combined with thrombolytic therapy.
Keywords:Ischemic cerebrovascular disease  Abciximab  Thrombolytic therapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号